by Raynovich Rod | Jul 14, 2013 | 2023-24 Life Science Portfolios, Life Science ETF's and Mutual Funds, Reading List
See This Week’s issue of Barron’s (JY 15 p 31) for a good summary of the biotech sector. See also our article at bottom of page from Investor Uprising in 2011.We have covered many ETFs and funds over the years and have favored Fidelity Select...
by Raynovich Rod | May 22, 2013 | BIOgraph, Reading List
Cancer’s Bitter Medicine Alex Philippidis in today’s Genetic Engineering News provides an excellent review of the treatment costs for CML (chronic myeloid leukemia) which can exceed $100k/year. However concern about the costs of cancer treatment has not...
by Raynovich Rod | May 20, 2013 | BIOgraph, Reading List
1999 Biotech Superstar Got Bailed Out By Anthrax antitoxin?! The famous Company that was going to revolutionize drug discovery was saved in 2003 by a government funded bioterror program for Anthrax and later a Lupus drug. Anthrax drug brings $334 million to Pentagon...
by Raynovich Rod | May 2, 2013 | Clinical Diagnostics and Tools, Reading List
Genomic Health Up 5% on Higher Q1 Revenues An article in the New York Times today (May 2) by Gina Kolata reviewed studies that affirmed the genetic basis of cancer. Genetic analysis of hundreds of tumors for endometrial cancer and leukemias found patterns of genetic...
by Raynovich Rod | Oct 17, 2012 | 2024 Rayno Tools and Diagnostics Portfolio, BIOgraph, Reading List
Ultimate Presidential Election Guide Click above for an interesting sector and stock review from Credit Suisse including major positions of candidates. Stocks in the Rayno Life Sciences Portfolio that were mentioned on the “Obama Victory” side include:...
by Raynovich Rod | Sep 17, 2012 | BIOgraph, Biopharmaceuticals, Reading List
The MASS Biotechnology industry has crossed $6B as a 25 year effort beginning in 1985 with the MASS Biotechnology Council. Several major biotechnology companies were created around this time such as Biogen(BIIB) and Vertex (VRTX) as well as major venture capital...
by Raynovich Rod | Aug 22, 2012 | Reading List, Weather//Ski Reports-Western US
End of LaNina? The weather is certainly in the news as drought approaches levels not seen since the 30’s. But several reports recently indicate a shift coming in the fall toward an El Nino pattern.I will check in with noted weather forecasters to see if the...
by Raynovich Rod | Jun 26, 2012 | BIOgraph, Reading List
Guide to Biotech Investing (Published in Investor Uprising in May 2011) This article is one year old but still relevant! Introduction: Balancing Portfolios With Biotech Rod Raynovich 5/27/2011 Recent breakthroughs with new drugs and devices have eclipsed many of the...
by Raynovich Rod | Jun 22, 2012 | Biopharmaceuticals, Macro, Reading List
BioBuzz Rolls On After a bad day on NASDAQ yesterday with some profit taking in biotech there is a lot of green screen today. The sector is up 1% today and we are near all time highs like the XBI ($86.92). But to many investors, biotechnology is relatively unknown or...
by Rod Raynovich | Jul 14, 2011 | 2023-24 Life Science Portfolios, BIOgraph, Reading List
Life Science Sector Outperforms NASDAQ-100: Movers are ROSGD, VICL Biotechnology stocks sold off about 0.65% overall as industry news and fundamentals were eclipsed by MACRO issues. Concerns loom about European debt, US debt ceiling and potential default. JPMorgan...
